Disfunción sexual en la hipertensión arterial

López-Ibor, 2002 Montejo, 2001, Incidence of sexual dysfunction associated to different antidepressant agents. A 5-year prospective and multicentric study in 1022 patients, J Clin Psychiatry, 62, 10 Rosen, 1997, The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction, Urology, 49, 822, 10.1016/S0090-4295(97)00238-0 Sánchez-Froilán S, Pérez M, Borrás JJ, Gómez O, Aznar J, Caballero A. Diseño y validación del Cuestionario de Función Sexual de la Mujer: FSM. [en prensa] Aten Primaria. Cabello Santamaría, 2002 Goldstein, 1998, Vasculogenic female sexual dysfunction: vaginal engorgement and clitoral erectile insufficiency syndromes, Int J Impot Res, 2, 84 Anderson, 1995, Physiology of penile erection, Physiol Rev, 75, 191, 10.1152/physrev.1995.75.1.191 Croog, 1986, The effects of antyhipertensive therapy on the quality of life, N Eng J Med, 314, 1657, 10.1056/NEJM198606263142602 Rosen, 1997, Sexual dysfunction as an obstacle to compliance with antihypertensive therapy, Blood Press, 1, 47 Burnett, 1995, Role of nitric oxide in the physiology of erection, Biol Reprod, 52, 485, 10.1095/biolreprod52.3.485 Boolell, 1996, Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction, Int J Impot Res, 8, 47 Web, 1999, Sildenafil citrate and blood-pressure-lowering drugs: results of drug interaction studies with an organic nitrate and calcium antagonist, Am J Cardiol, 83, 21, 10.1016/S0002-9149(99)00044-2 Cheitlin, 1999, Use of sildenafil (Viagra) in patients with cardiovascular disease. ACC/AHA Expert Consensus Document, Circulation, 99, 168, 10.1161/01.CIR.99.1.168 Sullivan, 1999, Nitric oxide and penile erection: is erectile dysfunction another manifestation of vascular disease?, Cardiovasc Res, 43, 658, 10.1016/S0008-6363(99)00135-2 Carroll, 1992, Impotence in the elderly. Evaluation of erectile failure in men older than seventy years of age, Urology, 39, 226, 10.1016/0090-4295(92)90295-8 Ribera, 1999, Involución sexual y disfunción eréctil, Rev Esp Geriatr Gerontol, 34, 1 Rajfer, 1992, Nitric oxide as a mediator of relaxation of the corpus cavernosum in response to non-adrenergic, non-cholinergic neurotransmission, N Engl J Med, 326, 90, 10.1056/NEJM199201093260203 Kadioglu, 1995, Evaluation of penile arterial system with color Doppler ultrasonography in nondiabetic and diabetic males, Eur Urol, 27, 311, 10.1159/000475187 Kelm, 1996, Evidence for a multifactorial process involved in the impaired flow response to nitric oxide in hypertensive patients with endothelial dysfunction, Hypertension, 27, 346, 10.1161/01.HYP.27.3.346 Morá-Maciá, 1998, Disfunción eréctil en hipertensos, Hipertensión, 6, 23 Fogari, 2002, Sexual activity and plasma testosterone levels in hypertensive males, Am J Hypertens, 15, 217, 10.1016/S0895-7061(01)02280-4 Jaffe, 1996, Erectile dysfunction in hypertensive subjects. Assessment of potencial determinants, Hipertensión, 28, 859, 10.1161/01.HYP.28.5.859 Bansal, 1988, Sexual dysfunction in hipertensive men. A critical rewiew of the literatura, Hypertension, 12, 1, 10.1161/01.HYP.12.1.1 Benet, 1995, The epidemiology of erectile dysfunction, Urol Clin North Am, 22, 699, 10.1016/S0094-0143(21)00690-X 1996, 1 Parazzini, 2000, Frequency and determinants of erectile dysfunction in Italy, Eur Urol, 37, 43, 10.1159/000020098 Feldman, 1994, Impotence and its medical and psychosocial correlates: results of the Massachussetts Male Aging Study, J Urol, 151, 54, 10.1016/S0022-5347(17)34871-1 Virag, 1985, Is impotence an arterial disorder? A study of arterial risk factors in 440 impotent men, Lancet, 1, 181, 10.1016/S0140-6736(85)92023-9 Johannes, 2000, Incidence of erectile dysfunction in men 40 to 70 years old: longitudinal results from the Massachusetts Male Aging Study, J Urol, 163, 460, 10.1016/S0022-5347(05)67900-1 Rosen, 2004, Men's Attitudes to Life Events and Sexuality (MALES) Study. The multinational Men's Attitudes to Life Events and Sexuality (MALES) study: I. Prevalence of erectile dysfunction and related health concerns in the general population, Curr Med Res Opin, 20, 607, 10.1185/030079904125003467 Martín-Morales, 2001, Prevalence and independent risk factors for erectile dysfunction in Spain: results of the Epidemiología de la Disfunción Eréctil Masculina Study, J Urol, 166, 569, 10.1016/S0022-5347(05)65986-1 Burchardt, 2000, Hypertension is associated with severe erectile dysfunction, J Urol, 164, 1188, 10.1016/S0022-5347(05)67138-8 Curb, 1985, Long-term surveillance for adverse effects of antyhipertensives drugs, JAMA, 253, 3263, 10.1001/jama.1985.03350460063022 Morales Concepción, 1989, Factores arteriales de riesgo en la impotencia sexual, Arch Esp Urol, 42, 905 Ferrer, 1998, Factores de riesgo en la disfunción sexual eréctil, An Cir Card Cir Vasc, 43, 105 Lue, 2000, Erectile dysfunction, N Engl J Med, 342, 1802, 10.1056/NEJM200006153422407 Hsueh, 1988, Sexual dysfunction with aging and systemic hypertension, Am J Cardiol, 61, 18, 10.1016/0002-9149(88)91100-9 Jensen, 1999, The prevalence and etiology of impotence in 101 male hypertensive outpatients, Am J Hypertens, 12, 271, 10.1016/S0895-7061(98)00225-8 Bansal, 1988, Sexual dysfunction in hypertensive men, Hypertension, 12, 1, 10.1161/01.HYP.12.1.1 Burchardt, 2000, Hypertension is associated with severe erectile dysfunction, J Urol, 164, 1188, 10.1016/S0022-5347(05)67138-8 Grimm, 1997, Long-term effects on sexual function of five antihypertensive drug and nutritional hygienic treatment in hypertensive men and women, Hypertension, 29, 8, 10.1161/01.HYP.29.1.8 Flack, 2002, The effect of doxazosin on sexual function in patients with benign prostatic hyperplasia, hypertension, or both, Int J Clin Pract, 56, 527, 10.1111/j.1742-1241.2002.tb11312.x Hanon, 1999, Antihypertensive treatment can normalize the geometry and the arterial function in the aged patient, Arch Mal Coeur Vaiss, 92, 1063 Cuéllar de León, 2002, Prevalencia de disfunción eréctil en pacientes con hipertensión arterial, Med Clin (Barc), 119, 521, 10.1016/S0025-7753(02)73483-0 Aranda, 2004, Erectile dysfunction in essential arterial hypertension and effects of sildenafil: results of a Spanish national study, Am J Hypertens, 17, 139, 10.1016/j.amjhyper.2003.09.006 Llisterri, 2000, Prevalencia de la disfunción sexual en una población hipertensa, Hipertensión, 6, 31 Mirone, 2004, Determinants of erectile dysfunction risk in a large series of Italian men attending andrology clinics, Eur Urol, 45, 87, 10.1016/j.eururo.2003.08.005 Guirao, 2002, Disfunción eréctil en atención primaria como posible marcador del estado de salud: factores asociados y respuesta al sildenafilo, Aten Primaria, 5, 290, 10.1016/S0212-6567(02)79030-6 Lipshultz, 1999, Treatment of erectile dysfunction in men with diabetes, JAMA, 281, 465, 10.1001/jama.281.5.465 Calle Pascual, 1997, Estimación de la prevalencia de disfunción eréctil en el varón con diabetes melllitus (DM) en la Comunidad de Madrid, Av Diabetol, 43, 80 Greenstein, 1997, Does severity of ischemic coronary disease correlate with erectile function?, Int J Impot Res, 9, 123, 10.1038/sj.ijir.3900282 Seftel, 2004, The prevalence of hypertension, hyperlipidemia, diabetes mellitus and depression in men with erectile dysfunction, J Urol, 171, 2341, 10.1097/01.ju.0000125198.32936.38 Foresta, 2004, Erectile dysfunction: symptom or disease?, J Endocrinol Invest, 27, 80, 10.1007/BF03350917 Karck, 1977, Toward the operational identification of adverse drug reactions, Clin Pharmacol Ther, 21, 247, 10.1002/cpt1977213247 Chang, 1991, The impact of diuretic therapy on reported sexual function, Arch Intern Med, 151, 2402, 10.1001/archinte.1991.00400120048008 1981, Adverse reactions to bendrofluazide and propranolol for the treatment of mild hypertension, Lancet, 2, 539 Wassertheil-Smoller, 1991, Effect of antihypertensive on sexual function and quality of life. The TAIM Sdudy, Ann Intern Med, 114, 613, 10.7326/0003-4819-114-8-613 Suzuki, 1988, Effects of firstline antihypertensive agents on sexual function and sex hormones, J Hypertens, 6, S649, 10.1097/00004872-198812040-00204 Stripp, 1975, Effect of spironolactone on sex hormones in man, J Clin Endocrinol Metab, 41, 777, 10.1210/jcem-41-4-777 Silvestri, 2003, Report of erectile dysfunction after therapy with beta-blockers is related to patient knowledge of side effects and is reversed by placebo, Eur Heart J, 24, 1928, 10.1016/j.ehj.2003.08.016 Rosen, 1988, Beta-blocker effects on sexual function in normal males, Arch Sex Behav, 17, 241, 10.1007/BF01541742 1981, Adverse reactions to bendrofluazide and propranolol for the treatment of mild hypertension, Lancet, 2, 539 Miller, 1976, Propranolol and impotence, Ann Intern Med, 85, 682, 10.7326/0003-4819-85-5-682_2 Burnett, 1979, Sexual dysfunction as a complication of propranolol therapy in men, Cardiovasc Med, 4, 811 Steiner, 1990, Antihypertensive therapy and quality of life: a comparison of atenolol, captopril, enalapril and propranolol, J Hum Hypertens, 4, 217 Fogari, 2002, Effect of antihypertensive treatment with valsartan or atenolol on sexual activity and plasma testosterone in hypertensive men, Eur J Clin Pharmacol, 58, 177, 10.1007/s00228-002-0456-3 Palmer, 1992, Quality of life in hypertensive treayed with atenolol or captopril: a double-blind crossover trial, J Hypertens, 10, 1409, 10.1097/00004872-199211000-00014 Testa, 1991, Assessment of quality of life by patients and spouse during antihypertensive therapy wit atenolol and nifedipine gastrointestinal therapeutic system, Am J Hypertens, 4, 363, 10.1093/ajh/4.4.363 Croog, 1990, Hypertensive black men and women. Quality of life and effects of antihypertensive medications. Black Hypertension Quality of Life Multicenter Trial Group, Arch Intern Med, 150, 1733, 10.1001/archinte.150.8.1733 Fogari, 2001, Sexual function in hypertensive males treated with valsartan or carvedilol: a cross-over Study, Am J Hypertens, 14, 27, 10.1016/S0895-7061(00)01214-0 Bulpitt, 1973, Side effects of hypontesive agents evaluated by a self administered questionnaire, Br Med J, 3, 485, 10.1136/bmj.3.5878.485 Saunders, 1980, Sexual activity in male hypertensive patients while taking clonidine, Uban Health, 1, 22 Yodfat, 1996, Quality of life in normotensives compared to hypertensive men treated with isradipine or methyldopa as monotherapy or in combination with captopril: the LOMIR-MCT-IL study, J Hum Hypertens, 10, 117 Weiss, 1991, Effects of antihypertensive agents on sexual function, Am Fam Physician, 44, 2075 Kolodny, 1981, Effects of alpha-methyldopa on male sexual function, Sexuality Disabil, 1, 223, 10.1007/BF01101329 Piha, 2003, Effects of moxonidine and metoprolol in penile circulation in hypertensive men with erectile dysfunction: results of a pilot study, Int J Impot Res, 15, 287, 10.1038/sj.ijir.3901007 Zlotta, 1999, BPH and sexuality, Eur Urol, 36, 107, 10.1159/000052330 Flack, 2002, The effect of doxazosin on sexual function in patients with benign prostatic hyperplasia, hypertension, or both, J Clin Pract, 56, 527, 10.1111/j.1742-1241.2002.tb11312.x Kaplan, 1998, Combination therapy using oral alpha-blockers and intracavernal injection in men with erectile dysfunction, Urology, 52, 739, 10.1016/S0090-4295(98)00388-4 Luther, 1988, Terazosin a new selective alpha 1-adrenergic blocking agent. Results of long-term treatment in patients with essential hypertension, Am J Hypertens, 1, 237S, 10.1093/ajh/1.3.237S Radomski, 1994, Topical minoxidil in the treatment of male erectile dysfunction, J Urol, 151, 1225, 10.1016/S0022-5347(17)35217-5 Fletcher, 1992, Quality of life with three antihypertensive treatments. Cilazapril, atenolol, nifedipine, Hypertension, 19, 499, 10.1161/01.HYP.19.6.499 Morrissette, 1993, Effects of antihypertensive drugs atenolol and nifedipine on sexual function in older men: a placebocontrolled, crossover study, Arch Sex Behav, 22, 99, 10.1007/BF01542360 Zachariah, 1988, Comparison of quality of life on nitrendipine and propranolol, J Cardiovasc Pharmacol, 12, S29, 10.1097/00005344-198806124-00007 Fletcher, 1989, The effects of verapamil and propranolol on quality of life in hypertension, J Hum Hypertens, 3, 125 Omvik, 1993, Double-blind, parallel, comparative study on quality of life during treatment with amlodipine or enalapril in mild or moderate hypertensive patients: a multicentre study, J Hypertens., 11, 103, 10.1097/00004872-199301000-00015 Prisant, 1999, Self Reported Sexual Dysfunction in Men and Women Treated With Bisoprolol, Hydrochlorothiazide, Enalapril, Amlodipine, Placebo, or Bisoprolol/Hydrochlorothiazide, J Clin Hypertens (Greenwich), 1, 22 Cushman, 1998, Comparison of the fixed combination of enalapril/diltiazem ER and their monotherapies in stage 1 to 3 essential hypertension, Am J Hypertens, 11, 23, 10.1016/S0895-7061(97)00372-5 Palmer, 1990, A comparison of verapamil and nifedipine on quality of life, Br J Clin Pharmacol, 30, 365, 10.1111/j.1365-2125.1990.tb03785.x Sociedad Española de Hipertensión-Liga Española para la Lucha contra la Hipertensión Arterial. Guía sobre el diagnóstico y el tratamiento de la hipertensión arterial en España 2002. Hipertens 2002; 19(Suppl 3):1-74. Sundar, 1991, The effects of antihypertensive agents on the quality of life in Indian hypertensives, Acta Cardiol, 46, 227 Fogari, 1998, Sexual function in hypertensive males treated with lisinopril or atenolol: a cross-over study, Am J Hypertens, 11, 1244, 10.1016/S0895-7061(98)00139-3 Croog, 1988, Sexual symptoms in hypertensive patients. A clinical trial of antihypertensive medications, Arch Intern Med, 148, 788, 10.1001/archinte.1988.00380040028006 Steiner, 1990, Antihypertensive therapy and quality of life: a comparison of atenolol, captopril, enalapril and propranolol, J Hum Hypertens, 4, 217 Kifor, 1997, Tissue angiotensin II as a modulator of erectile function. I. Angiotensin peptide content, secretion and effects in the corpus cavernosum, J Urol, 157, 1920, 10.1016/S0022-5347(01)64901-2 Chan, 1999, Effects of losartan on the sexual behavior of male rats, Pharmacology, 58, 132, 10.1159/000028275 Toblli, 2004, Candesartan cilexetil protects cavernous tissue in spontaneus hypertensive rats, Int J Impot Res, 16, 305, 10.1038/sj.ijir.3901146 Llisterri, 2001, Sexual dysfunction in hypertensive patients treated with losartan, Am J Med Sci, 321, 336, 10.1097/00000441-200105000-00006 Dusing, 2003, Effect of the angiotensin II antagonist valsartan on sexual function in hypertensive men, Blood Press (Suppl), 29, 10.1080/08038020310021967 Fogari, 2002, Effect of antihypertensive treatment with valsartan or atenolol on sexual activity and plasma testosterone in hypertensive men, Eur J Clin Pharmacol, 58, 177, 10.1007/s00228-002-0456-3 Della Chiesa, 2003, Sexual activity in hypertensive men, J Hum Hypertens, 17, 515, 10.1038/sj.jhh.1001580 Yamamoto, 2003, The effects of replacing dihydropyridine calcium-channel blockers with angiotensin II receptor blocker on the quality of life of hypertensive patients, Blood Press (Suppl), 2, 22, 10.1080/08038020310016378 Fogari, 2004, Effect of valsartan and atenolol on sexual behavior in hypertensive postmenopausal women, Am J Hypertens, 17, 77, 10.1016/j.amjhyper.2003.08.016 Fugl-Meyer, 1997, On life satisfaction in male erectile dysfunction, Intern J Impot Res, 9, 1414, 10.1038/sj.ijir.3900269 Rosen, 1998, Quality of life assessment in sexual dysfunction trials, Int J Impot Res, 10, S21 Cabello Santamaría, 2004 Sánchez-Froilán, 2003, La disfunción eréctil y otros trastornos sexuales en la consulta del médico de familia: ¡asumamos nuestro compromiso!, Semergen, 29-5, 227, 10.1016/S1138-3593(03)74183-5 Masters, 1995 Brotons F, Campos JC, González-Correales R, Martín-Morales A, Moncada I, Pomerol JM. Core document on erectile dysfunction: key aspects in the care of a patient with erectile dysfunction [en prensa]. Int J Impot Res. Goldstein, 1998, Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group, N Engl J Med, 338, 1397, 10.1056/NEJM199805143382001 Marks, 1999, Treatment of erectile dysfunction with sildenafil, Urology, 53, 19, 10.1016/S0090-4295(98)00525-1 Kloner, 2000, Cardiovascular risk and sildenafil, Am J Cardiol, 86, 57, 10.1016/S0002-9149(00)00895-X Web, 1999, Sildenafil citrate and blood-pressure-lowering drugs: rsults of drug interaction studies with an organic nitrate and calcium antagonist, Am J Cardiol, 83, 21, 10.1016/S0002-9149(99)00044-2 Hermann, 2000, Hemodynamic effects of sildenafil in men with severe coronary artery disease, N Eng J Med, 342, 1622, 10.1056/NEJM200006013422201 Arruda-Olson, 2002, Cardiovascular effects of sildenafil during exercise in men with known or probable coronary artery disease, JAMA, 287, 719, 10.1001/jama.287.6.719 Marwick, 2002, Safe sex for men with coronary artery disease. Exercise, sildenafil and risk of cardiac events, JAMA, 287, 766, 10.1001/jama.287.6.766 Ishikura, 2000, Effects of sildenafil citrate (Viagra) combined with nitrate on the heart, Circulation, 102, 2516, 10.1161/01.CIR.102.20.2516 Baumann, 2002, Sildenafil citrate is well tolerated in patients with erectile dysfunction and taking multiple antihypertensive medications, Int J Impotence Res, 14, S21 Mancia, 2002, Efficacy of Viagra (sildenafil) in men with erectile dysfunction who are taking multiple antihypertensive treatments, Am J Hypertens, 15, 55, 10.1016/S0895-7061(02)02413-5 Cheitlin, 1999, Use of sildenafil (Viagra) in patients with cardiovascular disease. ACC/AHA Expert Consensus Document, Circulation, 99, 168, 10.1161/01.CIR.99.1.168 Kuthe, 2003, Phosphodiesterase 5 inhibitors in male sexual dysfunction, Curr Opin Urol, 13, 405, 10.1097/00042307-200309000-00008 Fink, 2002, Sildenafil for male erectile dysfunction. A systematic review and meta-analysis, Arch Intern Med, 162, 1349, 10.1001/archinte.162.12.1349 Kloner, 2003, Cardiovascular effects of tadalafil in patients on common antihypertensive therapies, Am J Cardiol, 22, 47M, 10.1016/S0002-9149(03)00075-4